美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

美国抗疫概念

1,619.89

-1.0072-0.06%

涨家数：8

跌家数：10

平家数：1

市盈率：- -

高：1,628.16

开：1,620.90

低：1,615.07

收：1,620.90

成交量：1.06亿

成交额：57.38亿

市值：1.32万亿

流通市值：1.30万亿

数据加载中...

总览新闻资讯

BUZZ-美国 FDA 备忘录将儿童死亡与 COVID 疫苗注射联系起来后，疫苗制造商倒下了

持续引领HIV检测技术，雅培用创新科技布下一张“天罗地网”

雅培210亿美元收购Exact Sciences 进军癌症诊断领域

中国网财经

早筛的冰与火：雅培210亿美元吞下Exact Sciences，中国同行何以半壁凋零

华夏时报网

2025年，跨国巨头们为何集体“动刀”？

MedTrend医趋势

港股异动 | 和铂医药-B(02142)再涨超4% 与阿斯利康深化合作共同研发新一代肿瘤生物疗法

三生制药：707联合化疗的临床2期数据公布即将开展两项关键3期临床研究

创新高！华尔街看涨情绪浓厚强生(JNJ.US)市值首破5000亿美元

BioNTech建议CureVac股东在2025年12月2日星期二东部时间下午6点前递交其股票

阿斯利康：英飞凡获美国食品药品监督管理局批准

Valneva Se - 辉瑞计划在2026年向美国FDA提交生物许可证申请和向欧洲药品管理局提交上市授权申请

医药产业研究周报：Paradromics进临床，脑机赛道渐热；雅培百亿量级买Exact，数据淘金浪起

Abbott Medical旗下心肺功能测试系统类产品获FDA批准，注册证号为P100045 S087

阿斯利康投资20亿美元用于美国生物制品生产，同时RSV疫苗持久性与阿尔茨海默病药物试验面临挑战AstraZeneca Invests $2 Billion in US Biologics Manufacturing as RSV Vaccine Durability and Alzheimer’s Drug Trials Face Challenges

古根海姆上调辉瑞目标价至35美元

1160亿！雅培豪掷下注，打响“生命卡位战”！

Eshare医械汇

港股异动 | 和铂医药-B(02142)涨近5% 与阿斯利康进一步拓展合作范围开发ADC及T细胞衔接器疗法

这15家生物医药公司，市值超过1000亿美元！

脱发药龙头蔓迪国际递表港交所；和铂医药深化与阿斯利康的合作 | 医药早参

每日经济新闻

更正-雅培在美国对部分血糖监测仪的读数错误风险发布设备更正公告

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1619.8911,"timestamp":1764968399999,"preClose":1620.8983,"halted":0,"volume":106000681,"delay":0,"changeRate":-0.000621,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-1.007202,"latestTime":"12-05 16:00:00 EST","open":1620.9001,"high":1628.1649,"low":1615.068,"amount":5737825974.049658,"amplitude":0.00808,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.101106,"peRate":21.259406,"turnoverRate":0.006882,"increases":8,"decrements":10,"flats":1,"marketCap":1319585327514,"floatMarketCap":1300260491238},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1628.1649,"amplitude":0.00808,"preClose":1620.8983,"low":1615.068,"pbRate":"4.101106","latestPrice":1619.8911,"volume":106000681,"delay":0,"open":1620.9001,"prevYearClose":1274.8187,"prevWeekClose":1658.0673,"prevMonthClose":1658.0673,"prevQuarterClose":1508.8958,"fiveDayClose":1658.0673,"twentyDayClose":1536.9331,"sixtyDayClose":1507.3357,"secType":"PLATE","market":"US","turnoverRate":0.006882,"peRate":21.259406,"marketCap":1319585327514,"floatMarketCap":1300260491238,"timestamp":1764968399999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":8,"down":10,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588726730","title":"BUZZ-美国 FDA 备忘录将儿童死亡与 COVID 疫苗注射联系起来后，疫苗制造商倒下了","url":"https://stock-news.laohu8.com/highlight/detail?id=2588726730","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588726730?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 18:31","pubTimestamp":1764585097,"startTime":"0","endTime":"0","summary":"12月1日 - ** 疫苗制造商ModernaMRNA.O股价盘前下跌3.4%至25.10美元，NovavaxNVAX.O下跌1.4%至6.95美元。** 该备忘录没有透露这些儿童的健康状况，也没有透露所涉及的疫苗生产商；研究结果是基于对2021年至2024年期间96例死亡病例的初步分析得出的。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e18e4fc9b93eab8231ba72ae033af20d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nL4S3X70QD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","BK4581","BK4532","LU1883839398.USD","LU1057294990.SGD","LU0321505439.SGD","LU0225771236.USD","LU0306806265.USD","LU0456855351.SGD","LU0170899867.USD","BK4547","BK4007","SGXZ57979304.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0321505868.SGD","BK4550","LU1066051498.USD","BK4551","LU1894683264.USD","BK4533","LU0289739699.SGD","IE000M9KFDE8.USD","LU1894683348.USD","SG9999011175.SGD","IE00BBT3K403.USD","BK4139","LU0234572021.USD","SG9999013999.USD","SG9999002232.USD","BK4599","IE0002270589.USD","IE00B19Z3B42.SGD","NVAX","LU1023059063.AUD","BK4548","MRNA","BK4588","SG9999001176.SGD","SG9999003800.SGD","BK4585","SG9999001176.USD","LU0122379950.USD","LU0985481810.HKD","LU1066053197.SGD","BK4534","BK4501","BK4568","LU0868494617.USD"],"gpt_icon":1},{"id":"2588743413","title":"持续引领HIV检测技术，雅培用创新科技布下一张“天罗地网”","url":"https://stock-news.laohu8.com/highlight/detail?id=2588743413","media":"上观新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588743413?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 12:19","pubTimestamp":1764562789,"startTime":"0","endTime":"0","summary":"2025年12月1日是第38个“世界艾滋病日”。今年宣传活动主题为“社会共治，守正创新，终结艾滋”，旨在深刻认识艾滋病防治工作的重要性和长期性，在总结、继承既往有效防治工作经验和典型做法的基础上，进一步倡导社会各界共同承担艾滋病防治责任，加强艾滋病防治措施的探索创新，推进艾滋病防治工作高质量发展。病毒检测是艾滋病防治工作的重要一环。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512013579012625.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1691799644.USD","LU1914381329.SGD","LU2237957902.USD","LU2133065610.SGD","LU0234572021.USD","LU1989763690.USD","BK4533","SG9999002232.USD","LU1023059063.AUD","BK4592","LU0170899867.USD","LU2237957811.SGD","SG9999002224.SGD","LU1057294990.SGD","LU0266013472.USD","LU2112291526.USD","LU0882574055.USD","LU1721429402.USD","SGXZ23171101.USD","IE00B2B36J28.USD","BK4588","IE0002141913.USD","IE0009355771.USD","LU2089984988.USD","LU0122379950.USD","IE00BJT1NW94.SGD","LU0868494617.USD","LU1721429741.USD","ABT","LU2324357040.USD","LU0058720904.USD","BK4568","LU2211815571.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","BK4585","IE00BJJMRZ35.SGD","LU0114720955.EUR","BK4082","LU1061106388.HKD","BK4581","BK4566","LU0289739699.SGD","IE00B4R5TH58.HKD","SG9999004303.SGD","LU1989763427.SGD","BK4504"],"gpt_icon":0},{"id":"2587799474","title":"雅培210亿美元收购Exact Sciences 进军癌症诊断领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2587799474","media":"中国网财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587799474?lang=zh_cn&edition=fundamental","pubTime":"2025-11-30 17:13","pubTimestamp":1764494000,"startTime":"0","endTime":"0","summary":"中国网财经11月30日讯雅培近日宣布，将收购美国癌症诊断公司ExactSciences。交易预计将于2026年第二季度完成，但仍需获得ExactSciences股东的批准，并获得相关监管机构的批准和其他惯例成交条件。该交易得到了两家公司董事会的一致批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511303578443181.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511303578443181.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4585","LU1721429402.USD","BK4082","LU0114720955.EUR","LU0266013472.USD","LU2211815571.USD","SG9999002224.SGD","IE00BFTCPJ56.SGD","BK4592","LU2324357040.USD","LU1721429741.USD","LU2089984988.USD","LU2237957811.SGD","BK4504","LU0882574055.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU1691799644.USD","SG9999002232.USD","BK4533","LU0058720904.USD","ABT","SG9999004303.SGD","LU0289739699.SGD","IE0009355771.USD","LU0122379950.USD","IE00BJT1NW94.SGD","LU0170899867.USD","IE0002141913.USD","BK4566","LU0868494617.USD","LU0234572021.USD","LU1914381329.SGD","LU1989763427.SGD","SGXZ23171101.USD","BK4568","BK4588","IE00B4R5TH58.HKD","BK4581","LU1057294990.SGD","LU2133065610.SGD","LU2237957902.USD","LU2112291526.USD","LU1989763690.USD"],"gpt_icon":0},{"id":"2586978371","title":"早筛的冰与火：雅培210亿美元吞下Exact Sciences，中国同行何以半壁凋零","url":"https://stock-news.laohu8.com/highlight/detail?id=2586978371","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586978371?lang=zh_cn&edition=fundamental","pubTime":"2025-11-28 18:03","pubTimestamp":1764324220,"startTime":"0","endTime":"0","summary":"近日，2025年全球医疗领域最大收购案官宣，雅培210亿美元吞下早筛龙头。据悉，跨国医疗巨头雅培宣布以210亿美元（约合人民币1493亿元）全现金收购癌症早筛公司ExactSciences，以进军不断增长的多癌种早期检测市场。而这家总部位于美国威斯康星州的分子诊断公司，凭借其明星产品Cologuard——一款无创结直肠癌筛查测试，已成为美国癌症早筛市场的标杆企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511283577868445.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511283577868445.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2211815571.USD","LU1023059063.AUD","LU1061106388.HKD","LU0234572021.USD","LU0122379950.USD","SG9999004303.SGD","LU2089984988.USD","LU1057294990.SGD","BK4504","IE00BFTCPJ56.SGD","LU1989763427.SGD","IE00BJJMRZ35.SGD","LU1691799644.USD","BK4585","IE00B4R5TH58.HKD","BK4533","LU0882574055.USD","SGXZ23171101.USD","LU1914381329.SGD","BK4566","LU0289739699.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","LU0058720904.USD","BK4588","LU1721429402.USD","LU2468319806.SGD","LU0266013472.USD","LU0114720955.EUR","BK4082","IE0009355771.USD","LU2324357040.USD","BK4581","IE0002141913.USD","IE00B2B36J28.USD","LU2133065610.SGD","BK4592","LU0170899867.USD","SG9999002232.USD","LU2237957902.USD","LU2237957811.SGD","LU1721429741.USD","ABT","SG9999002224.SGD","BK4568","LU1989763690.USD","LU0868494617.USD"],"gpt_icon":0},{"id":"2586474992","title":"2025年，跨国巨头们为何集体“动刀”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474992","media":"MedTrend医趋势","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586474992?lang=zh_cn&edition=fundamental","pubTime":"2025-11-27 19:03","pubTimestamp":1764241412,"startTime":"0","endTime":"0","summary":"2025，一众跨国药企进入“瘦身”之年。据Fierce Biotech裁员追踪数据：2025年前三季度全球生物制药行业共190轮裁员，逼近2024年全年192轮的总量。大裁员背景下，从数据来看，进入2025年前三季度，MNC\"优等生\"阵营动荡，阿斯利康、默沙东、礼来、诺和诺德、诺华、赛诺菲6家MNC中国区增速均低于全球。整体来看，中国区裁员成熟药的退场是最大因素之一。进入下半年，诺和诺德计划裁员9000人，默沙东裁员6000人，单次裁员规模均远超2024年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127191618a4be0426&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127191618a4be0426&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFE","LU0321505439.SGD","LU2461242641.AUD","LU1989771016.USD","LU1069347547.HKD","LU2324357040.USD","LU1934455277.USD","BK4599","LU0203347892.USD","LU1699723380.USD","LU1894683264.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0265550359.USD","LU1093756325.SGD","IE0002270589.USD","BK4585","LU1934455863.HKD","LU1037948897.HKD","LU1974910355.USD","LU0122379950.USD","LU2361044865.SGD","SG9999014567.USD","LLY","LU2106854487.HKD","IE00B1BXHZ80.USD","LU0861579265.USD","LU1035773651.USD","LU1061106388.HKD","SG9999001176.USD","LU1934455194.USD","MRK","NVO","IE0002141913.USD","LU0070302665.USD","LU0965509101.SGD","IE00B4R5TH58.HKD","LU1291159041.SGD","SG9999011175.SGD","IE00BSNM7G36.USD","BK4588","IE00B2B36J28.USD","LU0098860793.USD","LU0225771236.USD","BK4568","SG9999015358.SGD","SG9999014559.SGD","LU1066051498.USD","LU0106261372.USD","LU1066051811.HKD","BK4533"],"gpt_icon":0},{"id":"2586876290","title":"港股异动 | 和铂医药-B(02142)再涨超4% 与阿斯利康深化合作 共同研发新一代肿瘤生物疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2586876290","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586876290?lang=zh_cn&edition=fundamental","pubTime":"2025-11-27 10:18","pubTimestamp":1764209891,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和铂医药-B再涨超4%，截至发稿，4.25%，报14.22港元，成交额2784.77万港元。消息面上，和铂医药发布公告，宣布将更新与深化推进其与阿斯利康于2025年3月建立的全球战略合作。根据协议，阿斯利康将在未来四年内，每年持续向和铂医药提名研发项目，并获得这些项目的授权许可选择权，彰显双方合作关系的持续深化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","BK4568","AZN","LU1829250122.USD","LU2462157665.USD","LU0889565916.HKD","LU0320765992.SGD","BK4007","LU2417539215.USD","02142","BK1574","LU2236285917.USD","LU0109394709.USD","BK1161","LU2456880835.USD","BK1583"],"gpt_icon":0},{"id":"2586225792","title":"三生制药：707联合化疗的临床2期数据公布 即将开展两项关键3期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2586225792","media":"国信证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586225792?lang=zh_cn&edition=fundamental","pubTime":"2025-11-27 07:57","pubTimestamp":1764201420,"startTime":"0","endTime":"0","summary":"近日，三生制药在2025 年STIC 会议上以LBA 方式发布707 联合化疗在一线NSCLC 的临床2 期研究数据。辉瑞与三生制药达成协议后，积极推进707 的临床开发，并将707 管线列为其核心管线，目前已经提交5 个新的临床申请，在全球超过25 个城市、500 多家临床中心开展临床研究，预计到2026 年底将新增10 个适应症的临床试验，以及10 个以上的新型治疗方案。辉瑞即将在NSCLC 和CRC 适应症中开展两项临床3 期研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127091749951c9fe5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127091749951c9fe5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0210528500.USD","LU0058720904.USD","LU1894683264.USD","SG9999001176.SGD","LU0234572021.USD","LU0053666078.USD","LU1057294990.SGD","LU0225284248.USD","IE000M9KFDE8.USD","BK4534","BK4599","IE00B19Z3B42.SGD","LU0225771236.USD","LU1894683348.USD","SG9999011175.SGD","LU0456855351.SGD","BK4550","BK4585","LU1066051498.USD","LU2487616109.SGD","LU0321505439.SGD","LU0306807586.USD","LU0321505868.SGD","IE00B19Z3581.USD","BK4568","BK4581","BK4007","SG9999002232.USD","LU0170899867.USD","LU0306806265.USD","LU0868494617.USD","LU0985481810.HKD","LU1023059063.AUD","BK4107","LU1066053197.SGD","LU0289739699.SGD","LU1883839398.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","BK4533","IE00BLSP4239.USD","LU0122379950.USD","SG9999013999.USD","SGXZ57979304.SGD","SG9999003800.SGD","IE0002270589.USD","BK4588","L","SG9999002224.SGD"],"gpt_icon":1},{"id":"2586296706","title":"创新高！华尔街看涨情绪浓厚 强生(JNJ.US)市值首破5000亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586296706","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586296706?lang=zh_cn&edition=fundamental","pubTime":"2025-11-27 07:44","pubTimestamp":1764200661,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，强生市值达到 5000 亿美元。周三，这家制药及医疗设备制造商的股价上涨了 0.4%，达到 207.56 美元，首次收于 5000 亿美元上方。强生公司正寄希望于新的药物和收购行动来补充其产品线，并弥补Stelara销量下滑所带来的损失。对于强生公司未来 12 个月的股价预期，市场普遍估计约为 205 美元，这比周三的收盘价略有下降。医药股的涨势主要得益于礼来公司,该公司股价今年已上涨 43%，上周还成为首家市值达到 1 万亿美元的制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B3PB1722.GBP","IE00BZ1G4Q59.USD","JNJ","LU0795875169.SGD","LU1674673428.USD","LU1244550221.USD","IE0002270589.USD","LU1023059063.AUD","BK4568","IE0034235303.USD","LU0345770993.USD","LU1066051498.USD","LU2129689605.HKD","BK4581","IE00BFXG1179.USD","LU0985320562.USD","BK4559","LU1894683348.USD","BK4588","IE00BGHQF631.EUR","LU0234572021.USD","BK4504","LU0795875086.SGD","IE00BFTCPJ56.SGD","LU1244550494.USD","LU2602419157.SGD","IE00B4R5TH58.HKD","IE00BBT3K403.USD","LU0466842654.USD","LU0122379950.USD","LU0889566641.SGD","LU0203345920.USD","IE00BDGV0183.EUR","LU2430703095.HKD","LU1074936037.SGD","IE00BSNM7G36.USD","LU1066051225.USD","LU1929549753.HKD","BK4007","LU0203347892.USD","LU1778281490.HKD","LU1162221912.USD","LU2347655156.SGD","LU2430703178.SGD","LU2471134523.USD","LU1506573853.SGD","IE00BLSP4239.USD","IE000M9KFDE8.USD","LU1732799900.SGD","LU1935042991.SGD"],"gpt_icon":0},{"id":"1174710771","title":"BioNTech建议CureVac股东在2025年12月2日星期二东部时间下午6点前递交其股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1174710771","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174710771?lang=zh_cn&edition=fundamental","pubTime":"2025-11-26 20:48","pubTimestamp":1764161321,"startTime":"0","endTime":"0","summary":"11月26日 - BioNTech SE宣布，CureVac于2025年11月25日举行的特别股东大会上批准了与其公开收购（“要约”）有关的事项，涉及CureVac N.V.（NASDAQ：CVAC，简称“CureVac”）的所有已发行股票。CureVac的股东被建议在2025年12月2日星期二东部时间下午6点之前递交他们的股票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4588","BK4139","BK4568","BNTX","BK4548","CVAC","BK4551","BK4585"],"gpt_icon":0},{"id":"2586825166","title":"阿斯利康：英飞凡获美国食品药品监督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2586825166","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586825166?lang=zh_cn&edition=fundamental","pubTime":"2025-11-26 20:03","pubTimestamp":1764158617,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4568","LU2236285917.USD","LU0109394709.USD","AZN","BK4007","BK4588","LU0320765992.SGD","LU2456880835.USD","LU2462157665.USD","LU1829250122.USD","LU2417539215.USD","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"1146660340","title":"Valneva Se - 辉瑞计划在2026年向美国FDA提交生物许可证申请和向欧洲药品管理局提交上市授权申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1146660340","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146660340?lang=zh_cn&edition=fundamental","pubTime":"2025-11-26 14:03","pubTimestamp":1764136992,"startTime":"0","endTime":"0","summary":"Valneva Se - 辉瑞计划在2026年向美国FDA提交生物许可证申请和向欧洲药品管理局提交上市授权申请","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1066051498.USD","LU0122379950.USD","LU0170899867.USD","LU0225284248.USD","SG9999002224.SGD","LU1057294990.SGD","LU1066053197.SGD","IE0002270589.USD","BK4588","BK4599","BK4568","LU0321505439.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1894683264.USD","BK4581","BK4585","LU0234572021.USD","SGXZ57979304.SGD","LU0289739699.SGD","IE00BBT3K403.USD","SG9999003800.SGD","BK4533","LU0058720904.USD","LU0225771236.USD","SG9999011175.SGD","PFE","BK4550","BK4534","IE00B19Z3581.USD","SG9999001176.SGD","LU1023059063.AUD","LU1883839398.USD","LU1894683348.USD","LU0456855351.SGD","SG9999002232.USD","LU0868494617.USD","LU0321505868.SGD","IE000M9KFDE8.USD","SG9999001176.USD","SG9999013999.USD","LU0985481810.HKD","LU0306806265.USD","LU0306807586.USD","BK4592","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2586233000","title":"医药产业研究周报：Paradromics进临床，脑机赛道渐热；雅培百亿量级买Exact，数据淘金浪起","url":"https://stock-news.laohu8.com/highlight/detail?id=2586233000","media":"国金证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586233000?lang=zh_cn&edition=fundamental","pubTime":"2025-11-26 12:06","pubTimestamp":1764129988,"startTime":"0","endTime":"0","summary":"产业前沿前沿动向：脑机接口卷起来，Nerulink对手Paradromics获批临床。数据生态：雅培210亿美元并购肠癌早筛公司ExactScience。本周，我们跟踪的全球1133只医药医疗股中，涨幅Top30的个股中，市值增长第一的是肠癌早筛公司ExactScience，一周市值上涨近64亿美元。因雅培将以210亿美元收购ExactSciences。我们认为，此项收购的意义，可能远不止是雅培看中Exact肠癌早筛产品Cologuard等。新一代技术的细胞基因疗法、AI制药等前沿赛道，或是2026年新热点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126120637977fe8ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126120637977fe8ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1691799644.USD","SGXZ23171101.USD","SG9999002232.USD","LU1914381329.SGD","LU1989763690.USD","LU1057294990.SGD","LU2237957811.SGD","BK4533","LU1721429402.USD","LU0170899867.USD","IE0009355771.USD","LU1989763427.SGD","LU0882574055.USD","LU2237957902.USD","IE0002141913.USD","BK4568","IE00BJJMRZ35.SGD","SG9999004303.SGD","LU2089984988.USD","LU0234572021.USD","BK4581","LU0114720955.EUR","IE00BJT1NW94.SGD","LU2324357040.USD","BK4585","LU0289739699.SGD","LU1061106388.HKD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU2211815571.USD","LU0266013472.USD","IE00B2B36J28.USD","BK4592","IE00B4R5TH58.HKD","SG9999002224.SGD","BK4566","LU2112291526.USD","BK4588","LU0058720904.USD","LU0122379950.USD","LU1721429741.USD","BK4504","ABT","LU2133065610.SGD","BK4082","LU2468319806.SGD"],"gpt_icon":0},{"id":"2586009233","title":"Abbott Medical旗下心肺功能测试系统类产品获FDA批准，注册证号为P100045 S087","url":"https://stock-news.laohu8.com/highlight/detail?id=2586009233","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586009233?lang=zh_cn&edition=fundamental","pubTime":"2025-11-26 09:51","pubTimestamp":1764121860,"startTime":"0","endTime":"0","summary":"产品名称：CardioMEMS™ HF System (Merlin.net PCN HF Portal (Model MN6000) and CardioMEMS Backend Web Application (Model CM4000))，所属单位：Abbott Medical，产品类型：心肺功能测试系统，产品详情：该产品是一款肺动脉压力监测系统，可帮助医疗专业人员主动管理和治疗患者的心力衰竭。审批机构：FDA，证件类型：三类，注册证编号：P100045 S087，获批时间：2025-11-10","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126095224a4ba9882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126095224a4ba9882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B2B36J28.USD","LU2237957902.USD","IE0009355771.USD","BK4585","BK4588","IE00BFTCPJ56.SGD","LU0122379950.USD","LU2468319806.SGD","LU0868494617.USD","LU1057294990.SGD","LU1023059063.AUD","LU2089984988.USD","IE00B4R5TH58.HKD","LU1914381329.SGD","LU2211815571.USD","SG9999002224.SGD","BK4592","BK4566","ABT","LU0882574055.USD","IE00BJJMRZ35.SGD","SG9999004303.SGD","LU1721429741.USD","LU2133065610.SGD","LU2237957811.SGD","SG9999002232.USD","LU0266013472.USD","LU1989763690.USD","LU0289739699.SGD","LU1061106388.HKD","BK4568","LU1721429402.USD","BK4581","BK4533","LU1989763427.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2324357040.USD","LU2112291526.USD","LU0114720955.EUR","SGXZ23171101.USD","BK4082","BK4504","IE0002141913.USD","LU0170899867.USD","LU1691799644.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2586715874","title":"阿斯利康投资20亿美元用于美国生物制品生产，同时RSV疫苗持久性与阿尔茨海默病药物试验面临挑战AstraZeneca Invests $2 Billion in US Biologics Manufacturing as RSV Vaccine Durability and Alzheimer’s Drug Trials Face Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2586715874","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586715874?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 22:28","pubTimestamp":1764080880,"startTime":"0","endTime":"0","summary":"报告显示，老年人接种RSV疫苗后保护效果的持久性正在随时间下降。The waning effectiveness of RSV vaccines raises concerns about long-term protection for older populations, prompting further evaluation of vaccine durability. AstraZeneca’s substantial investment underscores its commitment to expanding biologics capabilities within the U.S., with plans to bolster production infrastructure significantly.RSV疫苗效力的减弱引发了对老年人群长期保护的担忧，促使人们进一步评估疫苗的持久性。阿斯利康的巨额投资凸显了其致力于扩展在美国的生物制品能力，并计划大幅加强生产基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511252230349519bdfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511252230349519bdfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","BK4532","NVO","BK4007","AZN","BK4585","LU2462157665.USD","BK4588","LU0889565916.HKD","LU1829250122.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","LU2417539215.USD","LU2236285917.USD","BK4599","LU2456880835.USD","LU0320765992.SGD","BK4568","LU0109394709.USD","LU1093756325.SGD"],"gpt_icon":1},{"id":"2586425720","title":"古根海姆上调辉瑞目标价至35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586425720","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586425720?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 17:34","pubTimestamp":1764063257,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1066053197.SGD","LU0225771236.USD","LU0234572021.USD","IE00B19Z3B42.SGD","BK4592","SG9999001176.USD","LU0306806265.USD","LU0170899867.USD","BK4581","SG9999011175.SGD","IE00BLSP4239.USD","SG9999013999.USD","BK4585","BK4599","LU1023059063.AUD","IE0002270589.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","PFE","BK4550","LU0321505439.SGD","BK4568","SG9999001176.SGD","BK4588","IE00B19Z3581.USD","LU0456855351.SGD","LU1066051498.USD","LU1894683264.USD","SGXZ57979304.SGD","LU0985481810.HKD","IE00BBT3K403.USD","SG9999002232.USD","LU0289739699.SGD","LU1883839398.USD","LU0225284248.USD","LU0306807586.USD","LU0868494617.USD","LU0058720904.USD","BK4534","LU1057294990.SGD","SG9999003800.SGD","LU0122379950.USD","LU1894683348.USD","SG9999002224.SGD","BK4533","LU0321505868.SGD","BK4007"],"gpt_icon":0},{"id":"2586330702","title":"1160亿！雅培豪掷下注，打响“生命卡位战”！","url":"https://stock-news.laohu8.com/highlight/detail?id=2586330702","media":"Eshare医械汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586330702?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 17:01","pubTimestamp":1764061297,"startTime":"0","endTime":"0","summary":"要是交易达成，这极有可能成为2025年全球医疗行业规模最大的并购案，涉及金额约163亿美元，折合人民币1160亿，这标志着雅培在诊断领域的战略扩张迈向新阶段！Exact Sciences股价周三盘中暴涨29%，创近三年最大单日涨幅，最终收涨24%，公司市值直接攀升到约163亿美元。反观雅培，股价下跌3%，市值约2190亿美元。这次收购Exact Sciences，能强化雅培在癌症早筛领域的布局，和现有诊断业务形成协同效应。截至发稿，雅培和Exact Sciences双方都没回应置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125200319a7109780&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125200319a7109780&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1061106388.HKD","LU0266013472.USD","LU1914381329.SGD","LU1721429402.USD","IE00B4R5TH58.HKD","LU0170899867.USD","LU1057294990.SGD","LU1989763427.SGD","IE00B2B36J28.USD","LU0868494617.USD","LU2324357040.USD","SGXZ23171101.USD","LU1721429741.USD","BK4533","BK4592","SG9999004303.SGD","BK4504","LU0882574055.USD","BK4585","BK4588","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU1989763690.USD","SG9999002232.USD","LU2089984988.USD","IE0002141913.USD","LU1691799644.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2237957902.USD","ABT","LU0058720904.USD","BK4082","BK4566","LU0289739699.SGD","LU2468319806.SGD","IE00BJT1NW94.SGD","LU2237957811.SGD","LU2211815571.USD","BK4568","LU0122379950.USD","SG9999002224.SGD","LU0234572021.USD","LU2133065610.SGD","IE0009355771.USD","LU2112291526.USD","BK4581"],"gpt_icon":0},{"id":"2586341050","title":"港股异动 | 和铂医药-B(02142)涨近5% 与阿斯利康进一步拓展合作范围 开发ADC及T细胞衔接器疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2586341050","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586341050?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 10:23","pubTimestamp":1764037381,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和铂医药-B(02142)涨近5%，截至发稿，涨4.92%，报13.62港元，成交额1542.11万港元。消息面上，11月24日，和铂医药-B发布公告，有关公司的间接全资附属公司和铂医药(上海)有限责任公司(和铂上海)与AstraZeneca PLC (AstraZeneca)订立合作、选择权及许可协议，于2025年11月24日，经修订和铂上海与 AstraZeneca订立的合作协议后，订约双方的合作范围进一步扩展，旨在结合两家公司的专业知识，共同发现及开发包括抗体偶联药物(ADC)及T细胞衔接器在内的新一代生物疗法。经济条款与合作协议项下建立的财务框架仍然一致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","LU1829250122.USD","BK4007","BK1574","AZN","ADC","LU0109394709.USD","BK4588","LU0889565916.HKD","LU2417539215.USD","BK4080","LU0320765992.SGD","LU2236285917.USD","BK4585","BK1161","02142","BK4568","LU2456880835.USD","LU2462157665.USD","BK1583"],"gpt_icon":0},{"id":"2586541707","title":"这15家生物医药公司，市值超过1000亿美元！","url":"https://stock-news.laohu8.com/highlight/detail?id=2586541707","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586541707?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 08:18","pubTimestamp":1764029936,"startTime":"0","endTime":"0","summary":"截止到美股2025年11月24日盘前，已经有15家生物医药公司市值超过1000亿美元。其明星产品包括糖尿病药物Trulicity和Mounjaro，以及阿尔茨海默病药物Donanemab。财务亮点：市值高达1.00万亿美元，市盈率为54.41，股息率0.57%。但年初至今股价下跌35.62%，可能受监管压力或医疗成本上升影响。年初至今股价上涨41.85%，表现突出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125090047a70f4abd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125090047a70f4abd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJJMRZ35.SGD","SG9999001440.SGD","LU0098860793.USD","LU0985320562.USD","LU1974910355.USD","NVS","LU0266013472.USD","SG9999015341.SGD","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","LU0006306889.USD","BK4599","LU1883839398.USD","LU2089984988.USD","LU0203347892.USD","IE0002270589.USD","SG9999002232.USD","IE00B2B36J28.USD","SG9999013999.USD","IE00BN8TJ469.HKD","LU0058720904.USD","LU0106261372.USD","LU1983299246.USD","MRK","PFE","IE00B1BXHZ80.USD","IE00BSNM7G36.USD","CF","NVO","LU0238689110.USD","LU1116320901.HKD","BK4532","BK4523","LU1585245621.USD","LU0289739699.SGD","LU1934455277.USD","LU1934455863.HKD","IE0002141913.USD","LU1035773651.USD","LU0211331839.USD","LU0868494617.USD","LU0985481810.HKD","LU0154236417.USD","IE00BKVL7J92.USD","BK4568","LU0861579265.USD","LU1162221912.USD","LU1941712264.USD","UNH","LU0320765489.SGD","TTM","SG9999014542.SGD"],"gpt_icon":1},{"id":"2586416043","title":"脱发药龙头蔓迪国际递表港交所；和铂医药深化与阿斯利康的合作 | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2586416043","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586416043?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 07:45","pubTimestamp":1764027946,"startTime":"0","endTime":"0","summary":"丨2025年11月25日星期二丨NO.1和铂医药宣布与阿斯利康深化推进全球战略合作11月24日，和铂医药发布公告，称将更新与深化推进其与阿斯利康于今年3月建立的全球战略合作。在本次合作中，双方将基于各自专业技术知识，共同发现和开发包括抗体偶联药物（ADC）和T细胞衔接器（TCE）在内的新一代生物疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511253573501324.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511253573501324.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","LU2456880835.USD","09939","BK4007","159938","BK4568","BK1583","BK4588","LU2462157665.USD","LU0109394709.USD","AZN","LU1829250122.USD","LU0889565916.HKD","LU2236285917.USD","02142","BK1161","LU2417539215.USD","BK4585","BK1574","LU0320765992.SGD"],"gpt_icon":0},{"id":"2586949635","title":"更正-雅培在美国对部分血糖监测仪的读数错误风险发布设备更正公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2586949635","media":"路透中文","labels":["productRelease","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586949635?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 00:06","pubTimestamp":1764000376,"startTime":"0","endTime":"0","summary":"更正-雅培在美国对部分血糖监测仪的读数错误风险发布设备更正公告更正第 3 段，指出死亡病例均不发生在美国。雅培公司已在全球范围内收到736份严重不良事件报告，其中7人死亡可能与该问题有关。雅培公司表示，其他Libre产品、读取器和应用程序不受影响，在销售Libre 3和Libre 3 Plus传感器的其他国家也正在进行修正。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nL4T3X00YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU1057294990.SGD","LU0882574055.USD","BK4566","LU2089984988.USD","LU2211815571.USD","LU0114720955.EUR","BK4592","LU0234572021.USD","LU1023059063.AUD","SG9999004303.SGD","IE0009355771.USD","LU0289739699.SGD","LU1989763427.SGD","LU0170899867.USD","LU1914381329.SGD","LU1989763690.USD","IE0002141913.USD","LU0122379950.USD","LU1691799644.USD","BK4588","BK4504","LU0266013472.USD","LU1721429402.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","LU1721429741.USD","IE00BFTCPJ56.SGD","SG9999002224.SGD","IE00B2B36J28.USD","BK4082","SG9999002232.USD","IE00B4R5TH58.HKD","BK4585","LU0868494617.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","BK4581","BK4533","ABT","BK4568","LU2133065610.SGD","LU2237957902.USD","LU0058720904.USD","SGXZ23171101.USD","LU2237957811.SGD","LU2324357040.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":51,"code":"91000000","status":"200"}]}}